Blye; Richard P.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Blye; Richard P..The latest application filed is for "structural modification of 19-norprogesterone i: 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents".

Company Profile

2.11.12

Blye; Richard P. - Highland MD US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method of making and using 7.alpha., 11.beta.-dimethyl-17.beta.-hydroxyestr-4-en-3-one 17-undecanoate Grant 10,351,587 - Blye , et al. July 16, 2	2019-07-16
Structural Modification Of 19-norprogesterone I: 17-alpha-substituted-11-beta-substituted-4-aryl And 21-substituted 19-norpregnadienedione As New Antiprogestational Agents App 20140107089 - Kim; Hyun K. ; et al.	2014-04-17
Structural modification of 19-norprogesterone I: 17-.alpha.-substituted-11-.beta.-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents Grant 8,569,276 - Kim , et al. October 29, 2	2013-10-29
21-substituted progesterone derivatives as new antiprogestational agents Grant 8,003,629 - Kim , et al. August 23, 2	2011-08-23
Method Of Making And Using 7alpha, 11beta-dimethyl-17beta-hydroxyestr-4-en-3-one 17-undecanoate App 20110195942 - Blye; Richard P. ; et al.	2011-08-11
Nandrolone 17.beta.-carbonates Grant 7,820,642 - Blye , et al. October 26, 2	2010-10-26
21-substituted progesterone derivatives as new antiprogestational agents Grant 7,759,330 - Kim , et al. July 20, 2	2010-07-20
21-substituted Progesterone Derivatives As New Antiprogestational Agents App 20100113408 - Kim; Hyun K. ; et al.	2010-05-06
METHOD OF MAKING AND USING 7alpha,11beta-DIMETHYL-17beta-HYDROXYESTR-4-EN-3-ONE 17-UNDECANOATE App 20090023695 - Blye; Richard P. ; et al.	2009-01-22
Nandrolone 17 Beta-Carbonates App 20080167283 - Blye; Richard P. ; et al.	2008-07-10
Methods of making, using and pharmaceutical formulations comprising 7.alpha., 11.beta.-dimethyl-17.beta.-hydroxyestra-4, 14-dien-3-one and 17 esters thereof Grant 7,196,074 - Blye , et al. March 27, 2	2007-03-27
21-substituted progesterone derivatives as new antiprogestational agents App 20060276443 - Kim; Hyun K. ; et al.	2006-12-07
21-substituted progesterone derivatives as new antiprogestational agents Grant 7,087,591 - Kim , et al. August 8, 2	2006-08-08
21-Substituted progesterone derivatives as new antiprogestational agents App 20050143364 - Kim, Hyun K. ; et al.	2005-06-30
Structural modification of 19-norprogesterone I: 17-alpha-substituted-11-b- eta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents App 20050143365 - Kim, Hyun K. ; et al.	2005-06-30
Method of making and using 7alpha,11beta-dimethyl-17beta-hydroxyestr-4-en-- 3-one 17-undecanoate App 20050130944 - Blye, Richard P. ; et al.	2005-06-16
Structural modification of 19-norprogesterone I: 17-.alpha.-substituted-11-.beta.-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents Grant 6,900,193 - Kim , et al. May 31, 2	2005-05-31
21-substituted progesterone derivatives as new antiprogestational agents Grant 6,861,415 - Kim , et al. March 1, 2	2005-03-01
Methods of making, using and pharmaceutical formulations comprising 7alpha, 11beta-dimethyl-17beta-hydroxyestra-4, 14-dien-3-one and 17 esters thereof and 17 esters of 7alpha-methyl-17beta-hydroxyestra-4,14-di- en-3-one App 20030130243 - Blye, Richard P. ; et al.	2003-07-10
Methods of making and using 7a,11b-dimethyl-17b-hydroxy-4-estren-3-one 17b-trans-4-n-butylcyclohexane carboxylate and 7a,11b-dimethyl-17b-hydrox- yestr-4-en-3-one 17-undecanoate App 20030069215 - Blye, Richard P. ; et al.	2003-04-10
21-substituted Progesterone Derivatives As New Antiprogestational Agents App 20020025951 - KIM, HYUN K. ; et al.	2002-02-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.